(QDEL:Consolidated Issue Listed on NASDAQ Global Select )
Timothy T. Stenzel M.D., Ph.D.
Chief Scientific Officer, Quidel Corp.
|Age||Total Calculated Compensation||This person is connected to 28 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2012
Dr. Timothy T. Stenzel, also known as Tim, M.D., Ph.D., FACMG., has been the Chief Scientific Officer of Quidel Corp. since September 2009. Dr. Stenzel is responsible for technology assessment as well as implementing Quidel's molecular diagnostics strategy. He served as Chief Medical Officer and Vice President of Diagnostics Research and Development at Asuragen, Inc. Dr. Stenzel joined Asuragen, Inc. from Abbott Laboratories where he rose to Senior Director for Medical, ...
10165 McKellar CourtPhone: 858-552-1100
San Diego, California 92121
Board Members Memberships*
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John A. Kraeutler||Chief Executive Officer and Director|
Meridian Bioscience, Inc.
|Patrick J. Balthrop Sr.||Chief Executive Officer, President, Director, Member of Executive Committee and Member of Strategy & Development Committee|
|Douglas A. Michels||Chief Executive Officer, President and Director|
OraSure Technologies, Inc.
|Olivier Legrain||Chief Executive Officer, President and Director|
Ion Beam Applications, S.A.
|Michael K. McGarrity||Chief Executive Officer, President and Director|
|$298.5K||Compensation as of Fiscal Year 2013.|